NICE

News

Pfizer reaches deal with NICE on Vyndaqel for ATTR-CM

Three years after turning it down for being too expensive, NICE has backed the use of Pfizer’s Vyndaqel as a treatment for transthyretin amyloidosis with cardiomyopathy (A

News

NICE backs Novartis duo for NHS use in young glioma patients

An oral therapy that can allow children and adolescents with an aggressive form of brain cancer to be treated at home rather than in hospital has been recommended for use

News

NICE backs AbbVie’s oral therapy for migraine prevention

AbbVie’s Aquipta has become the first once-daily oral therapy for both chronic and episodic migraine prevention to be recommended by NICE for NHS patients in England and W

News

NICE backs use of post-stroke genetic testing

NICE has launched a new consultation on the use of CYP2C19 genotype testing to guide treatment after a stroke or transient ischaemic attack (TIA) or ‘mini-stroke’.

News

NICE endorses use of digital therapies for psychosis

Three digital health technologies (DHTs) used to support patients with psychosis can be used by the NHS while additional evidence of their benefits is gathered.

Market Access

Do better: The message to the industry from an analysis of c...

Dr Leeza Osipenko and colleagues analysed the quality of clinical evidence submitted by companies to NICE technology appraisals (TAs) over the last 20 years.

Pfizer reaches deal with NICE on Vyndaqel for ATTR-CM

NICE backs Novartis duo for NHS use in young glioma patients

NICE backs AbbVie’s oral therapy for migraine prevention

NICE backs use of post-stroke genetic testing

NICE endorses use of digital therapies for psychosis

Do better: The message to the industry from an analysis of c...

CDC panel votes to scrap hepatitis B birth dose advice

How to meet your physicians where they are online

NICE

Editor's Picks